譜尼測試(300887.SZ):變更保薦機構為華泰聯合證券
格隆匯11月4日丨譜尼測試(300887.SZ)公佈,公司近日與華泰聯合證券簽訂了相關的保薦協議,聘請華泰聯合證券擔任公司本次向特定對象發行股票的保薦機構。
自公司與華泰聯合證券簽署保薦協議之日起,華泰聯合證券將承接原國信證券對公司的有關持續督導職責,華泰聯合證券是經中國證監會核准的具有證券保薦承銷業務資格的證券公司。華泰聯合證券的持續督導期間為公司本次向特定對象發行股票並上市當年剩餘時間及其後兩個完整會計年度,並承接公司首次公開發行股票並在創業板上市的剩餘持續督導期內(至2023年12月31日止)的持續督導工作。
華泰聯合證券已委派保薦代表人劉曉寧和王禹負責本次向特定對象發行股票的保薦工作、股票上市後的持續督導工作及首次公開發行股票後續的持續督導工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.